1. Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence
   Diego Adrianzen Herrera et al, 2019, Expert Opinion on Pharmacotherapy CrossRef
2. A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer
   Hanjie Mo et al, 2022, Clinical Breast Cancer CrossRef
3. Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer
   Takeru Kashiwada et al, 2019, Japanese Journal of Clinical Oncology CrossRef
4. Paclitaxel-Induced Pneumonitis in Trinidad: A Case Report
   Nishtha Mohan et al, 2022, Cureus CrossRef
5. Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01)
   Susumu Takeuchi et al, 2023, Cancer Medicine CrossRef
6. A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
   Masaki Hanibuchi et al, 2018, Lung Cancer CrossRef
7. Gemcitabine plus nab‐paclitaxel for pancreatic cancer and interstitial lung disease: A nationwide longitudinal study
   Kei Saito et al, 2023, Cancer Science CrossRef
8. Pre-existing interstitial lung disease as a risk factor for pneumonitis associated with ramucirumab and paclitaxel in patients with gastric cancer: The impact of usual interstitial pneumonia
   Nobuyuki Koyama et al, 2018, PLOS ONE CrossRef
9. Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis
   Masahiro Yamasaki et al, 2019, Medicine CrossRef